Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruud H Brakenhoff

Showing results (131-140 of 192) with videos related to

Pageof 20
Sort By:
Molecular Cancer Therapeutics|December 17, 2016
The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional GenomicsSanne R Martens-de Kemp, Arjen Brink, Ida H van der Meulen, et al.
Oral Diseases|November 8, 2023
The value of regular follow-up of oral leukoplakia for early detection of malignant transformationIlkay Evren, Ahmad M Najim, Jos B Poell, et al.
Cancer Research|March 1, 2005
Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patientsHester J T van Zeeburg, Peter J F Snijders, Gerard Pals, et al.
Molecular Cancer Therapeutics|March 27, 2015
Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLCRemco Nagel, Marijke Stigter-van Walsum, Marijke Buijze, et al.
Stem Cell Research|March 26, 2013
CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell propertiesSanne R Martens-de Kemp, Arjen Brink, Marijke Stigter-van Walsum, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|August 19, 2008
Comparative evaluation of genetic assays to identify oral pre-cancerous fieldsJantine F Bremmer, Boudewijn J M Braakhuis, Arjen Brink, et al.
Cancers|April 28, 2019
Acute Hypoxia Profile is a Stronger Prognostic Factor than Chronic Hypoxia in Advanced Stage Head and Neck Cancer PatientsMartijn van der Heijden, Monique C de Jong, Caroline V M Verhagen, et al.
Oral Oncology|May 20, 2015
Molecular events in relapsed oral squamous cell carcinoma: Recurrence vs. secondary primary tumorFrederico O Gleber-Netto, Boudewijn J M Braakhuis, Asterios Triantafyllou, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2024
Secretome and immune cell attraction analysis of head and neck cancersTara Muijlwijk, Niels E Wondergem, Fatima Ekhlas, et al.
BMC Bioinformatics|August 22, 2018
Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selectionCosta Bachas, Jasmina Hodzic, Johannes C van der Mijn, et al.
Pageof 20

Showing results (131-140 of 192) with videos related to

Sort By:
Pageof 20
Molecular Cancer Therapeutics|December 17, 2016
The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional GenomicsSanne R Martens-de Kemp, Arjen Brink, Ida H van der Meulen, et al.
Oral Diseases|November 8, 2023
The value of regular follow-up of oral leukoplakia for early detection of malignant transformationIlkay Evren, Ahmad M Najim, Jos B Poell, et al.
Cancer Research|March 1, 2005
Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patientsHester J T van Zeeburg, Peter J F Snijders, Gerard Pals, et al.
Molecular Cancer Therapeutics|March 27, 2015
Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLCRemco Nagel, Marijke Stigter-van Walsum, Marijke Buijze, et al.
Stem Cell Research|March 26, 2013
CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell propertiesSanne R Martens-de Kemp, Arjen Brink, Marijke Stigter-van Walsum, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|August 19, 2008
Comparative evaluation of genetic assays to identify oral pre-cancerous fieldsJantine F Bremmer, Boudewijn J M Braakhuis, Arjen Brink, et al.
Cancers|April 28, 2019
Acute Hypoxia Profile is a Stronger Prognostic Factor than Chronic Hypoxia in Advanced Stage Head and Neck Cancer PatientsMartijn van der Heijden, Monique C de Jong, Caroline V M Verhagen, et al.
Oral Oncology|May 20, 2015
Molecular events in relapsed oral squamous cell carcinoma: Recurrence vs. secondary primary tumorFrederico O Gleber-Netto, Boudewijn J M Braakhuis, Asterios Triantafyllou, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2024
Secretome and immune cell attraction analysis of head and neck cancersTara Muijlwijk, Niels E Wondergem, Fatima Ekhlas, et al.
BMC Bioinformatics|August 22, 2018
Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selectionCosta Bachas, Jasmina Hodzic, Johannes C van der Mijn, et al.
Pageof 20